Which Companies Are In Michael King's Oncology Wheelhouse? Seeking Alpha I think chemotherapy will continue be used and Rituxan [rituximab; administered via infusion] will continue to be used, but now the new drugs will begin to be used in the relapse/refractory patient population. Researchers are also starting to see ... |
